<unk> , sold under the brand name Vosevi, is a fixed-dose combination medication for the treatment of hepatitis C. It combines three drugs that each act by a different mechanism of action against the hepatitis C virus:<unk> ,<unk> , and<unk> . Vosevi was approved for medical use in the United States and in the European Union in July 2017. Vosevi is sold by Gilead Sciences.
Sofosbuvir/velpatasvir/voxilaprevir
Ombitasvir/paritaprevir/ritonavir
Atazanavir/cobicistat
Abacavir/lamivudine/zidovudine
Atazanavir/ritonavir
Darunavir/cobicistat
Abacavir/lamivudine
Elbasvir/grazoprevir